Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies Completes Sale of Australian Genetics Business

NEW YORK(GenomeWeb) – Genetic Technologies today said that it has completed the sale of its heritage Australian Genetics business to Specialist Diagnostics Services for A$2 million (US$1.7 million) in cash. 

The sale was previously announced by GTG in September and followed the company's announced restructuring plans that included the divestiture of non-core assets in order to focus on its US molecular diagnostics operations and the commercialization of a new version of its BrevaGen breast cancer risk test. 

"The divesture of the Australian Genetics business represents another material milestone in our transformation to becoming a streamlined and focused molecular diagnostics company committed to the commercialization of our flagship breast cancer risk test, BrevaGenplus," GTG CEO Alison Mew said in a statement. "Implementation of the restructure plans continues and are on track for completion over the next quarter."

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.